Redx Pharma PLC operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Redx Pharma PLC with three other
companies in this sector in UNITED KINGDOM :
Deepmatter Group PLC
sales of £1.20 million [US$1.50 million]
of which 97%
Fusion Antibodies PLC
(£2.18 million [US$2.73 million]
Avacta Group Plc
(£3.89 million [US$4.86 million]
of which 60%
was Life Sciences).